Industry News
Biotechnology Industry News
Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes
Cassava CEO, ‘dazed and confused’, takes to biotech defense handbook by blaming short sellers for woes badams Fri, 09/03/2021 - 08:30
Rhythm, without missing a beat, installs Shapiro to replace departing CMO
Rhythm, without missing a beat, installs Shapiro to replace departing CMO ntaylor Fri, 09/03/2021 - 07:26
Pfizer, jumping headfirst into the RSV vaccine race, kickstarts phase 3 test
Pfizer, jumping headfirst into the RSV vaccine race, kickstarts phase 3 test badams Fri, 09/03/2021 - 07:21
Pfizer, jumping headfirst into the RSV vaccine race, kick-starts phase 3 test
Pfizer, jumping headfirst into the RSV vaccine race, kick-starts phase 3 test badams Fri, 09/03/2021 - 07:21
Novartis scraps kidney transplant trial after control beats study drug
Novartis scraps kidney transplant trial after control beats study drug ntaylor Fri, 09/03/2021 - 07:19
Not waving but drowning: Takeda’s blood cancer drug flunks phase 3, dealing further blow to hopes of approval flurry
Not waving but drowning: Takeda's blood cancer drug flunks phase 3, dealing further blow to hopes of approval flurry ntaylor Thu, 09/02/2021 - 08:19
Disc Medicine nabs $90M for blood disease pipeline, new Roche asset
Disc Medicine nabs $90M for blood disease pipeline, new Roche asset badams Thu, 09/02/2021 - 06:21
After one HBV flop, Assembly Biosciences forced to drop a hepatitis asset amid safety woes
After one HBV flop, Assembly Biosciences forced to drop a hepatitis asset amid safety woes badams Thu, 09/02/2021 - 05:59
Exit of Avidity CMO on cusp of first clinical trial sparks stock rout
Exit of Avidity CMO on cusp of first clinical trial sparks stock rout ntaylor Thu, 09/02/2021 - 05:44
HebeCell lands $53M, Chinese collaborator to make a splash in busy CAR-NK space
HebeCell lands $53M, Chinese collaborator to make a splash in busy CAR-NK space ntaylor Wed, 09/01/2021 - 08:25
After cutting dose because of deaths, Astellas pauses gene therapy trial as new liver issue arises
After cutting dose because of deaths, Astellas pauses gene therapy trial as new liver issue arises ntaylor Wed, 09/01/2021 - 06:33
J&J’s HIV vaccine fails phase 2b, extending long wait for an effective jab
J&J's HIV vaccine fails phase 2b, extending long wait for an effective jab ntaylor Tue, 08/31/2021 - 08:17
GSK, Korean biotech SK go head-to-head against AstraZeneca’s COVID-19 shot with their experimental vaccine
GSK, Korean biotech SK go head-to-head against AstraZeneca's COVID-19 shot with their experimental vaccine badams Tue, 08/31/2021 - 08:08
A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data
A year after a death and accompanying trial hold, Poseida hopes for reprieve with early solid tumor CAR-T data badams Tue, 08/31/2021 - 05:39
The descent of van de Stolpe: Galapagos CEO exits after R&D setbacks wipe out billions in value
The descent of van de Stolpe: Galapagos CEO exits after R&D setbacks wipe out billions in value ntaylor Tue, 08/31/2021 - 04:37
Brain cancer biotech Ziopharm snaps up new CEO from Kuur Therapeutics
Brain cancer biotech Ziopharm snaps up new CEO from Kuur Therapeutics klahucik Mon, 08/30/2021 - 09:48
Ziopharm snaps up new CEO from Kuur Therapeutics
Ziopharm snaps up new CEO from Kuur Therapeutics klahucik Mon, 08/30/2021 - 09:48
Pfizer’s abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain
Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain ntaylor Mon, 08/30/2021 - 08:44
SPAC backs Revelation to tackle respiratory viral infections
SPAC backs Revelation to tackle respiratory viral infections ntaylor Mon, 08/30/2021 - 08:02
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce cell death
Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce cell death arlene.weintraub Fri, 08/27/2021 - 10:59